Introduction
Intravascular coagulation may involve the kidneys in diseases such as thrombotic thrombocytopenic purpura and the haemolytic uraemic syndrome. In addition, fibrin deposition in the kidney has been found by light and fluorescence microscopy in other renal diseases, in particular in proliferative glomerulonephritis and lupus nephritis (Paronetto and Koffler, 1965) . There is inadequate information, however, on the extent to which fibrin formation is responsible for the renal disorder, on the mechanism by which fibrin is deposited in the kidneys, and on the types of renal disease which are associated with this process.
A sensitive method for the detection of fibrinogen or fibrin degradation appears to be estimation of serum levels of fibrinolytic degradation products (Ferreira and Murat, 1963; Merskey et al., 1966 Merskey et al., , 1967 . The term fibrinogen-fibrin-related antigen (F.R.-antigen) has been introduced in place of fibrinolytic degradation products because the assay technique is based on the antigenic similarity of non-clottable fragments to fibrinogen, and it is the former term which we will use in this paper. A major source of F.R.-antigen is probably intravascular fibrin deposits and it is thought that the production of serum F.R.-antigen is related both to the extent of the fibrin deposits and to the activity of the fibrinolytic and other proteolytic enzyme systems . Several studies have indicated that F.R.-antigen levels may be raised in the serum of patients with acute glomerulonephritis and acute reversible intrinsic renal failure (acute tubular necrosis) (Stiehm and Trygstad, 1968; Wardle and Taylor, 1968; McNicol et al., 1971) , and in the urine of patients with glomerulonephritis (Clarkson et al., 1971) , and rejecting renal transplants (Braun and Merrill, 1968; Clarkson et al., 1970a The underlying diseases in these 19 patients were: acute glomerulonephritis (1), chronic proliferative glomerulonephritis (4), membranous glomerulonephritis (1), chronic pyelonephritis (3), polycystic kidneys (2), phenacetin nephropathy (2), essential hypertension (4), miscellaneous (2).
M.H.A. was present in 18 patients (see Table) , in 16 of whom the serum F.R.-antigen level was raised. All these patients were uraemic (blood urea > 100 mg/100 ml), and in comparison with the remaining 68 uraemic patients they had a significantly higher incidence of raised F.R.-antigen levels (P < 002) (Fig. 2) .
Nineteen patients had malignant hypertension, of whom 10 had M.H.A. in addition. The 10 patients with both malignant hypertension and M.H.A. had significantly higher F.R.-antigen levels than the nine hypertensive patients without M.H.A. (P < 0 05) (Fig. 3) . However, the patients with malignant hypertension as a group did not have a higher incidence of raised F.R.-antigen than the remaining uraemic patients.
A higher proportion of the 86 uraemic patients had raised serum F.R.-antigen levels than the 56 in the non-uraemic group correlation between F.R.-antigen and the urine protein excretion (r = 0.577, P < 0 001) (Fig. 5 ).
Discussion
We found raised levels of serum F.R.-antigen in about half of a group of 142 patients with renal disease. These findings extend our earlier observations and confirm that only patients with acute reversible intrinsic renal failure had a higher incidence of raised serum F.R.-antigen levels in comparison with the other diagnostic categories. Intravascular coagulation within the glomeruli has been suggested as a factor in the pathogenesis of the acute renal failure resulting from renal ischaemia, in view of the finding of intraglomerular fibrin deposition (Clarkson et al., 1970b) , abnormalities in the coagulation and fibrinolytic systems, raised levels of serum F.R.-antigen (Wardle and Taylor, 1968) , and the excretion of urine F.R.-antigen during the recovery phase (Clarkson et al., 1970b (Wardle and Taylor, 1968) , pre-eclampsia (Bonnar et al., 1971) , and systemic complications after surgery (Wood et al., 1972) , and the high serum F.R.-antigen levels may be related more to proteolysis of in4avascular fibrin associated with the preceding illness than to the renal failure itself. Stiehm and Trygstad (1968) The association between raised serum F.R.-antigen and a wide variety of renal diseases could be explained on the basis that there is an increased tendency towards fibrin deposition and subsequent proteolytic digestion in them. Alternatively, the raised serum F.R.-antigen levels might reflect local intrarenal fibrin deposition as a result of endothelial damage. Fibrinoid change in small blood vessels is seen not only in malignant hypertension (Kincaid-Smith et al., 1958) but also in other conditions, including polyarteritis (Pickering, 1961) , and there is evidence to suggest that the fibrinoid material is composed mainly of fibrin (Lendrum, 1964; Ooneda et al., 1965 . This sequence of events would explain the finding that raised serum F.R.-antigen levels are sometimes associated with evidence of decreased fibrinolytic activity, which is known to . 8 occur in renal disease (McNicol et al., 1965; Wardle et al., 1970; Prentice et al., 1972) , although Pandolfi et al. (1970) showed that the activator content of renal vessels is independent of the degree of uraemia.
Raised levels of urine F.R.-antigen were present in 34 of 38 patients but did not correlate with the type of renal disease, serum F.R.-antigen level, or severity of the renal failure. We found, as did Clarkson et al. (1971) that there were wide variations in the amounts of urine F.R.-antigen from day to day in the same patient. The lack of correlation between the serum and urine F.R.-antigen levels, and the presence in 14 patients of raised urine F.R.-antigen together with normal serum levels supports previous evidence that urine F.R.-antigen appears as a result of local fibrinogen or fibrin degradation in the kidney (Humair et al., 1969) . On the other hand, correlation between the amounts of F.R.-antigen and of protein in the urine suggests that part of the urine F.R.-antigen concentration is derived by glomerular filtration. Although raised urinary F.R.-antigen has been described previously in a variety of renal diseases (Rayner et al., 1969; Clarkson et al., 1970b) , the wide range of results obtained in diagnostic groups precludes any use as a diagnostic aid, except possibly in the detection of incipient renal transplant rejection (Braun and Merrill, 1968; Carlsson et al., 1970; Clarkson et al., 1970a) . Additionally, serial assays may be of use as a prognostic guide (Clarkson et al., 1971 ).
An important problem is whether F.R.-antigen is an almost irrelevant by-product of basic renal disease which will continue on its way uninfluenced by therapeutic measures, or whether the immediate mechanism which produces F.R.-antigen is central to the pathogenesis of the disease. It might be that heparin, for example, could control some of the manifestations of renal Case History An unemployed 16-year-old girl took about 15 300 mg tablets of quinine sulphate (4.5 g) on the evening of 20 September 1970. They had been prescribed for her mother's night cramps and were swallowed as a suicide gesture after a family row. She vomited several times that night and found by the following morning she was virtually blind though otherwise perfectly well. She was admitted to St. Mary's Hospital, London, at noon on 21 September.
On examination she was fully conscious, with regular pulse and normal blood pressure. The only abnormal physical findings were ocular. She was only just able to distinguish light from dark; the pupils were widely dilated and just reacted to light. Her fundi appeared entirely normal.
MANAGEMENT
Forced diuresis was begun after stomach washout. Initial investigations showed a normal haematological picture, urea, and electroytes. The serum quinine level was 7-2 mg/l. Inhalation of amyl nitrite produced flushing of the conjunctivae but no subjective visual improvement or fundal changes. Three hours after admission bilateral stellate ganglion block was performed (Dr. K. Herdman). A dose of 10 ml of 5% Marcain was injected each side.
